ISOTECHNIKA INC. CONSOLIDATED BALANCE SHEET  
As at May 31,1999
(Unaudited)
 
 
1999
1998
ASSETS
 
Current
Term deposits, treasury bills and money market fund
$ 1,648,995
-
Accounts Receivable
277,864
693,813
Inventories
549,016
185,004
Prepaid expenses and deferred costs
57,701
135,591

  2,533,576
1,014,408
 
Capital assets, net
729,621
1,292,053
Patent costs
674,951
465,495
Deferred start-up costs
-
57,167

 
$ 3,938,148
$2,829,123



LIABILITIES
 
Current
Bank indebtedness
$ 454,555
$ 63,391
Bank demand loans
930,000
-
Accounts payable and accrued liabilities
1,152,009
1,136,298
Promissory Note
20,000
150,000
Current portion of obligations under capital leases
37,063
57,712
Current portion of long-term debt
-
138,205

  2,593,627
1,545,606
 
Obligations under capital leases
40,729
80,735
Long-term debt
75,000
107,653

 
2,709,356
1,733,994

 
Shareholders' Equity
Share capital Issued 27,258,376 shares (1997 - 24,218,376)
10,171,178
7,077,067
Deficit
(8,942,386)
(5,981,938)

  1,228,792
1,095,129

  $ 3,938,148
$ 2,829,123



ISOTECHNIKA INC. CONSOLIDATED STATEMENT OF OPERATIONS AND DEFICIT  
For the three months ended May 31, 1999
(Unaudited)
 
 
1999
1998
Revenue
Product sales and contract analysis
$ 987,121
$ 655,841
Licensing, royalties and other
307,066
267,935
Interest
47,258
1,793

  1,341,445
925,569

 
Expenses
Research and development
891,820
999,692
Selling and administration
655,197
761,093
Cost of product sales and contract analysis
629,096
443,090
Depreciation & amortization
145,710
223,563
Interest on long-term debt
4,418
22,697

 
2,326,241
2,450,135

 
(984,796)
(1,524,566)
 
Other Income
Research and development tax credits
417,844
210,277

 
Net loss for the period
(566,952)
(1,314,289)
Deficit, beginning of period
(8,375,434)
(4,667,649)

 

Deficit, end of period
$ (8,942,386)
$ (5,981,938)



Loss per share
$ 0.02
$ (0.05)



ISOTECHNIKA INC. CONSOLIDATED STATEMENT OF CHANGES IN FINANCIAL POSITION  
For the three months ended May 31, 1999
(Unaudited)
 
 
1999
1998
Operating activities
 
Net loss for the period
$ (566,952)
$ (1,314,289)
Item not affecting cash Depreciation & amortization
145,710
223,563
Net change in non-cash compnents of working capital
(608,691)
(469,516)

  (1,029,933
(1,560,242)
 
Investing activities
 
Purchase of capital assets
(15,327)
(224,752)
Scientific research and development tax credit related to capital assets
28,499
71,568
Patent costs
(35,721)
(31,430)

  (22,549)
(184,614)
 
Financing activities
 
Bank demand loans
930,000
-
Promissory notes
-
150,000
Repayment of promissory notes and loans payable
(1,522,000)
-
Obligations under capital leases
-
112,400
Repayment of capital leases
(39,383)
(88,075)
Repayment of long-term debt
-
(27,483)
Issuance of share capital, net of share issue costs
3,101,324
1,303,899

  2,469,941
1,450,741

 
Increase (decrease) in cash
1,417,459
(294,115)
 
Cash position, beginning of period
(223,019)
230,724

Cash position, end of period
$1,194,440
$(63,391)


Cash position is defined as term deposits, treasury bills and money market fund less bank indebtedness.
 
Approved on behalf of the Board
Doug Walker, Director      Joseph Koziak, Director